Exclusive-Grammarly acquires email startup Superhuman in AI platform push:

Image source: Adobe Stock

Grammarly has acquired email efficiency tool Superhuman as part of the company's push to build an artificial intelligence-powered productivity suite and diversify its business, its executives told Reuters in an interview.

The San Francisco-based companies declined to disclose the financial terms of the deal. Superhuman, once an exclusive email tool boasting a long waitlist for new users, was last valued at $825 million in 2021, and currently has an annual revenue of about $35 million.

Grammarly's acquisition of Superhuman follows its recent $1 billion funding from General Catalyst, which gives it dry powder to create a collection of AI-powered workplace tools. Founded in 2005, the company has over 40 million daily users and an annual revenue exceeding $700 million.

It's working on a name change with an ambition to expand beyond grammar correction.

Superhuman, with over $110 million in funding from investors including IVP and Andreessen Horowitz, has been trying to create an efficient email experience by integrating AI. MarketScreener reports.

👟 Nike stock soars 17% after CEO soothes investors, says recovery is on the horizon: Nike stock soared 17% on Friday after the company said the worst of its struggles are behind it, following a better-than-feared fiscal fourth-quarter earnings report.

Nike on Thursday reiterated it would take the biggest financial hit from its turnaround plan during the quarter, soothing investors who worried President Donald Trump’s tariff hikes on key Nike manufacturing hubs like China and Vietnam would derail the company’s comeback.

Nike posted a poor fourth quarter, as sales dropped 12%, net income plunged 86% and profit margins dwindled. But CEO Elliott Hill stressed the company has emerged from the worst of its slump, and the slide in sales and profits would begin to moderate in the quarters ahead. CNBC reports.

👩‍🔬 Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot: Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and Covid jab.

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza, saying it had plans to resubmit it with efficacy data from the phase three trial on its stand-alone flu vaccine.

That decision came after discussions with the Food and Drug Administration, which is grappling with a massive overhaul under Health and Human Services Secretary Robert F. Kennedy Jr., a prominent vaccine skeptic.

With the new data, the company plans to resubmit the application for the combination vaccine and file for approval of its stand-alone flu shot later this year, Stephen Hoge, the company’s head of research and development, said in an interview. CNBC reports.

🚀 NASA plans to stream rocket launches on Netflix starting this summer: NASA’s live programming, including rocket launches, spacewalks and views of Earth from space, will begin streaming on Netflix this summer.

NASA said the move is part of its effort to reach a global audience, according to a press release. The agency noted that the content will remain free and ad-free on the NASA app and website, where it already has live programming.

NASA+ launched in 2023 as a way to give the public easier access to space content.

“The National Aeronautics and Space Act of 1958 calls on us to share our story of space exploration with the broadest possible audience,” Rebecca Sirmons, general manager of NASA+, said in the release. CNBC reports.

🏠 Home Depot is buying GMS for about $4.3 billion as retailer chases more home pros: Home Depot said Monday that it is buying GMS, a building products distributor, for about $4.3 billion as the retailer moves to draw more sales from contractors and other home professionals.

Shares of Home Depot fell nearly 1% on Monday. GMS shares rose about 12% and touched a 52-week high.

As part of the deal, the Home Depot-owned subsidiary SRS Distribution will purchase all outstanding shares of GMS for $110 per share, which adds up to about $4.3 billion and amounts to total enterprise value including net debt of about $5.5 billion, the company said. CNBC reports.

🏦 US Senate Republicans struggling to unite on Trump's $3.3 trillion tax-cut bill: U.S. Senate Republicans were struggling to pass President Donald Trump's sweeping tax-cut and spending bill early on Tuesday, amid deep divisions within the party about its expected $3.3 trillion hit to the nation's debt pile.

The Senate remained in session through the night, voting on a long series of amendments, part of the arcane process Republicans are using to bypass Democratic objections under Senate rules that normally require 60 of the chamber's 100 members to agree on legislation.

In the pre-dawn hours, the lawmakers voted 99-1 to strip out a 10-year federal moratorium on state regulation of artificial intelligence, which supporters had promoted as a way to free innovation from a panoply of differing requirements. Market Screener reports.

🚙 New Tesla sales in Spain rise 61% in June: Tesla's new car sales in Spain rose 60.7% in June from the same month in 2024 to 2,632 vehicles, registration data released by industry group ANFAC showed on Tuesday, as sales of all electrified cars more than doubled.

In the first half of the year though sales of Tesla cars in Spain fell 0.9% from the same period a year earlier, while total sales of electrified vehicles, a category that includes both fully electric vehicles and hybrids, were up 83%. Market Screener reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.

1) $BGLC: BioNexus Gene Lab

Total gain: +329.96%

2) $CLRO: ClearOne

Total gain: +167.13%

3) $OGEN: Oragenics

Total gain: +56.28%

4) $APG: APi Group

Total gain: +19.32%

5) $BMNR: BitMine Immersion Techs

Total gain: +16.04%

The closing price of the top three market percent gainers trading near or above $3 on June 30.
Benzinga reports.

*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time

1) $BMNR: Bitmine Immersion Technologies

Total gain: +677.72%

The company announced the pricing and signing of a private placement for the purchase and sale of 55,555,556 shares of common stock at a price of $4.50 per share, for expected aggregate gross proceeds of approximately $250 million, fore deducting placement agent fees and other offering e expenses, to implement an Ethereum treasury strategy. StreetInsider reports.

2) $IPDN: Professional Diversity

Total gain: +90.28%

The company has announced a major expansion across North America for its FOCUSfactor® supplements and functional beverage brands, spanning mass, grocery, convenience, and wholesale channels. Benzinga reports.

3) $WBUY: Webuy Global

Total gain: +37.83%

The company has successfully integrated Coinbase Commerce into its platform, enabling customers worldwide to pay for travel packages and products using hundreds of cryptocurrencies, including the stablecoin USDC. This strategic move underscores Webuy's commitment to digital innovation and positions the company at the forefront of travel technology and next-generation payment solutions. Benzinga reports.

*Estimate and Actual numbers represent Earnings Per Share in US Dollars


STZ: Constellation Brands
1Q 2026

After Market Close
Estimate: 3.290
Actual: N/A

TTGT: TechTarget
1Q 2025

After Market Close
Estimate: 0.120
Actual: N/A

GBX: Greenbrier Companies
3Q 2025

After Market Close
Estimate: 0.990
Actual: N/A

Time (ET) / Report / Period

9:30 am - Fed Chair Jerome Powell speech

9:45 am - S&P final U.S. manufacturing PMI - June

10:00 am - Construction spending - May

“Every trader has strengths and weaknesses. Some are great analysts, but can’t pull the trigger. Others can but don’t know when to sell. The best traders learn how to work around their weaknesses.”

- Jack D. Schwager

Sourced in: “The New Market Wizards: Conversations with America’s Top Traders”, by Jack D. Schwager, published in 1992.